Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Schroeder

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
HIV Research & Clinical Practice|May 26, 2026
Italy is ready-extended PrEP cascade, and determinants of intention to use long-acting PrEP and unmet PrEP needs among men who have sex with men, trans* individuals, heterosexual women, and menHaoyi Wang, Johann Kolstee, Hanne M L Zimmermann, et al.
Respiratory Medicine|June 6, 2024
The long-term clinical and economic benefits of treating advanced COPD patients with single-inhaler triple therapy in Quebec, Canada - The IMPACT trialNancy A Risebrough, Sara Mursleen, Kerigo Ndirangu, et al.
Clinical Therapeutics|May 24, 2022
Comparative Efficacy and Safety of Fostemsavir in Heavily Treatment-Experienced People With HIV-1Sarah-Jane Anderson, Alexander van Doornewaard, Matthew Turner, et al.
AIDS and Behavior|January 24, 2026
Exploring the Interest and Intention to Use Long-Acting Injectable PrEP (LAI-PrEP) Among Gay, Bisexual and Other Men Who Have Sex with Men (GBMSM) in the NetherlandsJohann Kolstee, Haoyi Wang, Hanne Zimmermann, et al.
Infectious Diseases and Therapy|July 5, 2025
Indirect Treatment Comparison of Long-Acting Injectable Cabotegravir as Pre-exposure Prophylaxis When Compared with no Pre-exposure Prophylaxis for HIV PreventionNeil Hawkins, Paul O'Brien, Juliette Thompson, et al.
ERJ Open Research|March 29, 2021
Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UKElisabeth Fenwick, Alan Martin, Melanie Schroeder, et al.
HIV Research & Clinical Practice|April 7, 2026
Enthusiasm and hesitation: a structural topic modelling analysis of long-acting injectable PrEP perceptions among Dutch-speaking MSMHaoyi Wang, Johann Kolstee, Jonathan Tosh, et al.
Scientific Reports|July 27, 2016
Multi-Scale Correlative Tomography of a Li-Ion Battery Composite CathodeRiko Moroni, Markus Börner, Lukas Zielke, et al.
ERJ Open Research|February 24, 2022
Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trialAlan Martin, Dhvani Shah, Kerigo Ndirangu, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 5, 2020
Treatment Preferences of Patients with Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups in the United Kingdom, United States, and GermanyMelanie Schroeder, Katie Hall, Lina Eliasson, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
HIV Research & Clinical Practice|May 26, 2026
Italy is ready-extended PrEP cascade, and determinants of intention to use long-acting PrEP and unmet PrEP needs among men who have sex with men, trans* individuals, heterosexual women, and menHaoyi Wang, Johann Kolstee, Hanne M L Zimmermann, et al.
Respiratory Medicine|June 6, 2024
The long-term clinical and economic benefits of treating advanced COPD patients with single-inhaler triple therapy in Quebec, Canada - The IMPACT trialNancy A Risebrough, Sara Mursleen, Kerigo Ndirangu, et al.
Clinical Therapeutics|May 24, 2022
Comparative Efficacy and Safety of Fostemsavir in Heavily Treatment-Experienced People With HIV-1Sarah-Jane Anderson, Alexander van Doornewaard, Matthew Turner, et al.
AIDS and Behavior|January 24, 2026
Exploring the Interest and Intention to Use Long-Acting Injectable PrEP (LAI-PrEP) Among Gay, Bisexual and Other Men Who Have Sex with Men (GBMSM) in the NetherlandsJohann Kolstee, Haoyi Wang, Hanne Zimmermann, et al.
Infectious Diseases and Therapy|July 5, 2025
Indirect Treatment Comparison of Long-Acting Injectable Cabotegravir as Pre-exposure Prophylaxis When Compared with no Pre-exposure Prophylaxis for HIV PreventionNeil Hawkins, Paul O'Brien, Juliette Thompson, et al.
ERJ Open Research|March 29, 2021
Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UKElisabeth Fenwick, Alan Martin, Melanie Schroeder, et al.
HIV Research & Clinical Practice|April 7, 2026
Enthusiasm and hesitation: a structural topic modelling analysis of long-acting injectable PrEP perceptions among Dutch-speaking MSMHaoyi Wang, Johann Kolstee, Jonathan Tosh, et al.
Scientific Reports|July 27, 2016
Multi-Scale Correlative Tomography of a Li-Ion Battery Composite CathodeRiko Moroni, Markus Börner, Lukas Zielke, et al.
ERJ Open Research|February 24, 2022
Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trialAlan Martin, Dhvani Shah, Kerigo Ndirangu, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 5, 2020
Treatment Preferences of Patients with Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups in the United Kingdom, United States, and GermanyMelanie Schroeder, Katie Hall, Lina Eliasson, et al.
Pageof 3